Bicara Therapeutics Inc. - BCAX

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A Vestal Point Capital, LP 8.3% 5,425,000 View
May 15, 2026 SCHEDULE 13G/A Ryan Wilder 8.3% 5,425,000 View
May 15, 2026 SCHEDULE 13G JANUS HENDERSON GROUP PLC 5.1% 3,339,218 View
May 15, 2026 SCHEDULE 13G/A Deep Track Capital, LP 6.21% 4,062,500 View
May 15, 2026 SCHEDULE 13G/A Deep Track Biotechnology Master Fund, Ltd. 6.21% 4,062,500 View
May 15, 2026 SCHEDULE 13G/A David Kroin 6.21% 4,062,500 View
May 08, 2026 SCHEDULE 13G/A Red Tree GP, LLC 4.8% 3,170,509 View
May 08, 2026 SCHEDULE 13G/A Red Tree Venture Fund, L.P. 4.8% 3,170,509 View
May 08, 2026 SCHEDULE 13G/A Heath Lukatch 4.8% 3,170,509 View
May 06, 2026 SCHEDULE 13G/A FMR LLC 3.2% 2,100,929 View
May 06, 2026 SCHEDULE 13G/A Abigail P. Johnson 3.2% 2,100,929 View
Apr 08, 2026 SCHEDULE 13G/A T. Rowe Price Investment Management, Inc. 10.1% 6,605,780 View
Mar 02, 2026 SCHEDULE 13D/A — 9.99% — View
Feb 17, 2026 SCHEDULE 13G T. Rowe Price Investment Management, Inc. 5.9% 3,236,595 View
Feb 17, 2026 SCHEDULE 13G/A Vestal Point Capital, LP 6.5% 3,575,000 View
Feb 17, 2026 SCHEDULE 13G/A Ryan Wilder 6.5% 3,575,000 View
Feb 12, 2026 SCHEDULE 13G Deep Track Capital, LP 5.02% 2,750,000 View
Feb 12, 2026 SCHEDULE 13G Deep Track Biotechnology Master Fund, Ltd. 5.02% 2,750,000 View
Feb 12, 2026 SCHEDULE 13G David Kroin 5.02% 2,750,000 View
Feb 05, 2026 SCHEDULE 13G/A FMR LLC 6.1% 3,347,223 View
Feb 05, 2026 SCHEDULE 13G/A Abigail P. Johnson 6.1% 3,347,223 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.